| # | Drug | Count |
|---|---|---|
| 0 | DIAZEPAM | 12 |
| 1 | DIAZEPAM ORAL | 12 |
| 2 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 12 |
| 3 | VENLAFAXINE | 12 |
| 4 | VENLAFAXINE HYDROCHLORIDE | 12 |
| 5 | MIRTAZAPINE | 10 |
| 6 | FLUOXETINE HYDROCHLORIDE | 9 |
| 7 | ALPRAZOLAM | 8 |
| 8 | CLONAZEPAM | 8 |
| 9 | CARBOPLATIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 1 | OXAZEPAM | 6 | 0.0003 |
| 2 | NINTEDANIB | 7 | 0.0002 |
| 3 | CALCIUM ACETATE | 1 | 0.0002 |
| 4 | DIAZEPAM ORAL | 12 | 0.0001 |
| 5 | LITHIUM | 3 | 0.0001 |
| 6 | MIRTAZAPINE | 10 | 0.0001 |
| 7 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 8 | DIAZEPAM | 12 | 0.0001 |
| 9 | VENLAFAXINE HYDROCHLORIDE | 12 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 18 |
| 1 | Atypical Antipsychotic [EPC] | 7 |
| 2 | Microtubule Inhibitor [EPC] | 7 |
| 3 | Platinum-based Drug [EPC] | 7 |
| 4 | Corticosteroid [EPC] | 2 |
| 5 | Estrogen [EPC] | 2 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 7 | Aromatic Amino Acid [EPC] | 1 |
| 8 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 |
| 9 | Calcium Channel Blocker [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 1 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 2 | Benzodiazepine [EPC] | 18 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 7 | 0.0000 |
| 4 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 5 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 6 | Aromatic Amino Acid [EPC] | 1 | 0.0000 |
| 7 | Atypical Antipsychotic [EPC] | 7 | 0.0000 |
| 8 | Estrogen [EPC] | 2 | 0.0000 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |